COMPARE CPM-RMI Trial: Intramyocardial Transplantation of Autologous Bone Marrow-Derived CD133+ Cells and MNCs during CABG in Patients with Recent MI: A Phase II/III, Multicenter, Placebo-Controlled, Randomized, Double-Blind Clinical Trial (vol 20, pg 449, 2018)

被引：0

作者：

Naseri, Mohammad Hassan ^{[1
]}

Madani, Hoda ^{[2
]}

Tafti, Seyed Hossein Ahmadi ^{[3
]}

Farahani, Maryam Moshkani ^{[4
]}

Saleh, Davood Kazemi ^{[5
]}

Hosseinnejad, Hossein ^{[6
]}

Hosseini, Saeid ^{[7
]}

Hekmat, Sepideh ^{[8
]}

Ahmadi, Zargham Hossein ^{[9
]}

Dehghani, Majid ^{[6
]}

Saadat, Alireza ^{[10
]}

Mardpour, Soura ^{[2
]}

Hosseini, Seyedeh Esmat ^{[2
,11
]}

Esmaeilzadeh, Maryam ^{[12
]}

Sadeghian, Hakimeh ^{[3
]}

Bahoush, Gholamreza ^{[13
]}

Bassi, Ali ^{[14
,17
]}

Amin, Ahmad ^{[15
,16
]}

Fazeli, Roghayeh ^{[2
]}

Sharafi, Yaser ^{[10
]}

Arab, Leila ^{[2
]}

Movahhed, Mansour ^{[8
]}

Davaran, Saeid ^{[3
]}

Ramezanzadeh, Narges ^{[3
]}

Kouhkan, Azam ^{[2
]}

Hezavehei, Ali

Namiri, Mehrnaz ^{[2
]}

Kashfi, Fahimeh ^{[18
]}

Akhlaghi, Ali ^{[18
]}

Sotoodehnejadnematalahi, Fattah ^{[2
]}

Dizaji, Ahmad Vosough ^{[19
]}

Gourabi, Hamid ^{[20
]}

Syedi, Naeema ^{[21
]}

Shahverdi, Abdolhosein ^{[2
]}

Baharvand, Hossein ^{[2
]}

Aghdami, Nasser ^{[2
]}

机构：

[1] Baqiyatallah Univ Med Sceinces, Dept Surg, Tehran, Iran

[2] ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Regenerat Med, POB 16635-148, Tehran, Iran

[3] Univ Tehran Med Sci, Res Dept, Tehran Heart Ctr, Tehran, Iran

[4] Baqiyatallah Univ Med Sceinces, Dept Echocardiog, Tehran, Iran

[5] Baqiyatallah Univ Med Sceinces, Dept Cardiol, Tehran, Iran

[6] Lavasani Hosp, Social Secur Org, Dept Cardiac Surg, Tehran, Iran

[7] Iran Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Tehran, Iran

[8] Univ Tehran Med Sci, Dept Nucl Med, Hasheminejad Hosp, Tehran, Iran

[9] Shaheed Beheshti Univ Med Sci, Masih Daneshvari Hosp, NRITLD, Transplantat Res Ctr, Tehran, Iran

[10] Baqiyatallah Univ Med Sceinces, Dept Internal Med, Tehran, Iran

[11] Shahid Beheshti Univ Med Sci, Sch Nursing & Midwifery, Student Res Comm, Tehran, Iran

[12] Iran Univ Med Sci, Echocardiog Res Ctr, Rajaie Cardiovasc Med & Res Ctr, Tehran, Iran

[13] Univ Tehran Med Sci, Dept Pediat, Ali Asghar Pediat Hosp, Tehran, Iran

[14] Iran Univ Med Sci, Firoozgar Hosp, Dept Hematol & Oncol, Tehran, Iran

[15] Iran Univ Med Sci, Dept Heart Failure & Transplantat, Tehran, Iran

[16] Iran Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Heart Failure & Transplantat, Tehran, Iran

[17] Lavasani Hosp, Social Secur Org, Dept Internal Med, Tehran, Iran

[18] ACECR, Dept Epidemiol & Reprod Hlth, Reprod Epidemiol Res Ctr, Royan Inst Reprod Biomed, Tehran, Iran

[19] ACECR, Dept Reprod Imaging, Reprod Biomed Res Ctr, Royan Inst Reprod Biomed, Tehran, Iran

[20] ACECR, Dept Genet, Reprod Biomed Res Ctr, Royan Inst Reprod Biomed, Tehran, Iran

[21] Univ S Australia, Sansom Inst Hlth Res, Sch Pharm & Med Sci, Adelaide, SA, Australia

来源：

CELL JOURNAL | 2018年 / 20卷 / 03期

关键词：

D O I：

暂无

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：449 / 449

页数：1

共 10 条

[1] COMPARE CPM-RMI Trial: Intramyocardial Transplantation of Autologous Bone Marrow-Derived CD133+ Cells and MNCs during CABG in Patients with Recent MI: A Phase II/III, Multicenter, Placebo-Controlled, Randomized, Double-Blind Clinical Trial
Naseri, Mohammad Hassan
Madani, Hoda
Tafti, Seyed Hossein Ahmadi
Farahani, Maryam Moshkani
Saleh, Davood Kazemi
Hosseinnejad, Hossein
Hosseini, Saeid
Hekmat, Sepideh
Ahmadi, Zargham Hossein
Dehghani, Majid
Saadat, Alireza
Mardpour, Soura
Hosseini, Seyedeh Esmat
Esmaeilzadeh, Maryam
Sadeghian, Hakimeh
Bahoush, Gholamreza
Bassi, Ali
Amin, Ahmad
Fazeli, Roghayeh
Sharafi, Yaser
Arab, Leila
Movahhed, Mansour
Davaran, Saeid
Ramezanzadeh, Narges
Kouhkan, Azam
Hezavehei, Ali
Namiri, Mehrnaz
Kashfi, Fahimeh
Akhlaghi, Ali
Sotoodehnejadnematalahi, Fattah
Dizaji, Ahmad Vosough
Gourabi, Hamid
Syedi, Naeema
Shahverdi, Abdolhosein
Baharvand, Hossein
Aghdami, Nasser
CELL JOURNAL, 2018, 20 (02) : 267 - 277
[2] PHASE III RANDOMIZED CLINICAL TRIAL COMPARING THE EFFECTS OF AUTOLOGOUS BONE MARROW DERIVED MNC AND CD133 CELLS TRANSPLANTATION IN AMI PATIENTS DURING CABG
Nasseri, M. H.
Aghdami, N.
Ahmadi, H.
Farahani, M. Moshkani
Madani, H.
Kazemi-Saleh, D.
Hossein-neghad, H.
Hosseini, S.
Hekmat, S.
Ahmadi, Z.
Dehghani, M.
Saadat, A.
Mardpour, S.
Hosseini, E. S.
Esmaeelzadeh, M.
Sadeghi, M.
Bahoosh, G.
Bassi, A.
Amin, A.
Fazeli, R.
Sharafi, Y.
Arab, L.
Movahed, M.
Ramazanzadeh, N.
Kohkan, A.
Hezavee, A.
Namiri, M.
Kashfi, F.
Akhlaghi, A.
Baharvand, H.
Vosough, A.
Gourabi, H.
Shahverdi, A.
CYTOTHERAPY, 2013, 15 (04) : S12 - S12
[3] INTRAPORTAL INFUSION OF BONE MARROW MONONUCLEAR OR CD133+CELLS IN PATIENTS WITH DECOMPENSATED CIRRHOSIS: A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL
Vosough, M.
Aghdami, N.
Baharvand, H.
Malekzadeh, R.
Mohammadnejad, M.
JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S210 - S210
[4] Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Safety and Therapeutic Efficacy of Angiogenesis Induced by Intraarterial Autologous Bone Marrow-Derived Stem Cells in Patients with Severe Peripheral Arterial Disease
Sharma, Sanjiv
Pandey, Niraj Nirmal
Sinha, Mumun
Kumar, Sanjeev
Jagia, Priya
Gulati, Gurpreet Singh
Gond, Kalpnath
Mohanty, Sujata
Bhargava, Balram
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2021, 32 (02) : 157 - 163
[5] Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia
Powell, Richard J.
Comerota, Anthony J.
Berceli, Scott A.
Guzman, Raul
Henry, Timothy D.
Tzeng, Edith
Velazquez, Omaida
Marston, William A.
Bartel, Ronnda L.
Longcore, Amy
Stern, Theresa
Watling, Sharon
JOURNAL OF VASCULAR SURGERY, 2011, 54 (04) : 1032 - 1041
[6] Effects of Transendocardial Delivery of Bone Marrow-Derived CD133+ Cells on Left Ventricle Perfusion and Function in Patients With Refractory Angina Final Results of Randomized, Double-Blinded, Placebo-Controlled REGENT-VSEL Trial
Wojakowski, Wojciech
Jadczyk, Tomasz
Michalewska-Wludarczyk, Aleksandra
Parma, Zofia
Markiewicz, Miroslaw
Rychlik, Wojciech
Kostkiewicz, Magdalena
Gruszczynska, Katarzyna
Blach, Anna
Dzierzak-Mietla, Monika
Wanha, Wojciech
Ciosek, Joanna
Ochala, Beata
Rzeszutko, Lukasz
Cybulski, Wieslaw
Partyka, Lukasz
Zasada, Wojciech
Wludarczyk, Witold
Dworowy, Sebastian
Kuczmik, Waclaw
Smolka, Grzegorz
Pawlowski, Tomasz
Ochala, Andrzej
Tendera, Michal
CIRCULATION RESEARCH, 2017, 120 (04) : 670 - +
[7] Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: Results of a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial
Shadmanfar, Soraya
Labibzadeh, Narges
Emadedin, Mohsen
Jaroughi, Neda
Azimian, Vajiheh
Mardpour, Soura
Kakroodi, Fatemeh Abbasi
Bolurieh, Tina
Hosseini, Seyyedeh Esmat
Chehrazi, Mohammad
Niknejadi, Maryam
Baharvand, Hossein
Gharibdoost, Farhad
Aghdami, Nasser
CYTOTHERAPY, 2018, 20 (04) : 499 - 506
[8] Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction (vol 158, pg 356, 2009)
Vaughan, Douglas E.
AMERICAN HEART JOURNAL, 2009, 158 (06) : 1045 - 1045
[9] Transplantation efficacy of autologous bone marrow mesenchymal stem cells combined with atorvastatin for acute myocardial infarction (TEAM-AMI): rationale and design of a randomized, double-blind, placebo-controlled, multi-center, Phase II TEAM-AMI trial
Xu, Jun-Yan
Qian, Hai-Yan
Huang, Pei-Sen
Xu, Jun
Xiong, Yu-Yan
Jiang, Wen-Yang
Xu, Yi
Leng, Wen-Xiu
Li, Xiang-Dong
Chen, Gui-Hao
Tang, Rui-Jie
Huang, Cun-Rong
Hu, Meng-Jin
Jin, Chen
Wu, Yuan
Zhang, Jun
Qian, Jie
Xu, Bo
Zhao, Shi-Hua
Lu, Min-Jie
Shen, Rui
Fang, Wei
Wu, Wei-Chun
Chen, Xi
Wang, Yang
Li, Wei
Lu, Xiang-Feng
Jiang, Xi-Feng
Ma, Chun-Cheng
Li, Jian-Wen
Geng, Yong-Jian
Qiao, Shu-Bin
Gao, Run-Lin
Yang, Yue-Jin
REGENERATIVE MEDICINE, 2019, 14 (12) : 1077 - 1087
[10] Abstract of the 20th International Anniversary MASCC/ISOO Symposium: A Phase III randomized double-blind placebo controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation (vol 15, pg 651, 2007)
Schubert, M. M.
Eduardo, F. P.
Guthrie, K. A.
Franquin, J. C.
Bensadoun, R. J.
Migliorati, C. A.
Hamdi, M.
Niccoli-Filho, W.
SUPPORTIVE CARE IN CANCER, 2007, 15 (11) : 1331 - 1332

← 1 →